Phase II study of tolerance and efficacy of hyperfractionated radiotherapy and 5-fluorouracil, cisplatin, and paclitaxel (Taxol) in stage III and IV inoperable and/or unresectable head-and-neck squamous cell carcinoma: A-2 protocol (Q40579457)
Jump to navigation
Jump to search
scientific article published on July 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II study of tolerance and efficacy of hyperfractionated radiotherapy and 5-fluorouracil, cisplatin, and paclitaxel (Taxol) in stage III and IV inoperable and/or unresectable head-and-neck squamous cell carcinoma: A-2 protocol |
scientific article published on July 2002 |
Statements
1 reference
Phase II study of tolerance and efficacy of hyperfractionated radiotherapy and 5-fluorouracil, cisplatin, and paclitaxel (Taxol) in stage III and IV inoperable and/or unresectable head-and-neck squamous cell carcinoma: A-2 protocol (English)
1 reference
Andre Abitbol
1 reference
May Abdel-Wahab
1 reference
Alan Lewin
1 reference
Michael Troner
1 reference
Maria Amelia Rodrigues
1 reference
Kara L Hamilton-Nelson
1 reference
Arnold Markoe
1 reference
1 July 2002
1 reference
1 reference
53
1 reference
4
1 reference
942-947
1 reference
Identifiers
1 reference
1 reference